EKRE, Hans-Peter,ERIKSSON, Per-Olov,LINDAHL, Ulf,HOLMER, Erik
申请号：
DK12858809
公开号：
DK2794665T3
申请日:
2012.12.19
申请国别(地区):
DK
年份:
2018
代理人:
摘要：
The present invention relates to a chemically modified glycosaminoglycan with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw, weight average) from about 4.6 to 6.9 kDa. Also disclosed is a method of preparing the modified glycosaminoglycan and its medical uses.
